Àå±â ÀÌ½Ä¿ë ¸é¿ª¾ïÁ¦Á¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¾à¹° Á¾·ùº°, ÀÌ½Ä À¯Çüº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends Analysis Report By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents), By Transplant Type, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1611100
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 110 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àå±â ÀÌ½Ä¿ë ¸é¿ª¾ïÁ¦Á¦ ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, Àå±â ÀÌ½Ä¿ë ¸é¿ª¾ïÁ¦Á¦ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2025-2030³â±îÁö ¿¬Æò±Õ 4.7%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇϸç 2030³â¿¡´Â 72¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. Àå±â À̽ÄÀÌ ÇÊ¿äÇÑ È¯ÀÚ ¼ö Áõ°¡¿Í ½Å±Ô Á¦Ç° ½ÂÀÎ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù. ±×·¯³ª ³ôÀº ÀÌ½Ä ½Ã¼ú ºñ¿ë, Àå±â °ø±Þ°ú ¼ö¿äÀÇ ºÒ±ÕÇü, ºÒÅõ¸íÇÑ »óȯ ½Ã³ª¸®¿À´Â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

º¸°ÇÀÚ¿ø¼­ºñ½ºÃ»°ú ¹Ì±¹ º¸°Çº¹ÁöºÎ¿¡ µû¸£¸é 2019³â 1¿ù ±âÁØ 11¸¸ 3,000¸í ÀÌ»óÀÌ À̽ÄÀ» ÇÊ¿ä·Î Çϰí ÀÖÀ¸¸ç, 2018³â¿¡´Â 3¸¸ 6,528°ÇÀÇ À̽ÄÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù. µû¶ó¼­ Àå±â À̽Ŀ¡ ´ëÇÑ ¼ö¿ä´Â ¾öû³ª°Ô ¸¹À¸¸ç, ÀÌ´Â ½ÃÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ½ÅÀå À̽ÄÀº ÀÌ½Ä ºÎ¹®¿¡¼­ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ µ¿¾È ¼±µÎ¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¼ö¿äÀÇ Áõ°¡¿Í ´Ù¸¥ Àå±âº¸´Ù ½ÅÀåÀÌ »ó´ëÀûÀ¸·Î ´õ ½±°Ô ±¸ÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù.

¾à¹° Á¾·ùº°·Î´Â Ä®½Ã´º¸° ¾ïÁ¦Á¦°¡ ¿¹Ãø ±â°£ µ¿¾È Àü ¼¼°è Àå±â ÀÌ½Ä¿ë ¸é¿ª¾ïÁ¦Á¦ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ¾à¹°±º¿¡´Â ÇÁ·Î±×¶óÇÁ(Ÿũ·Î¸®¹«½º)¿Í »êµð¹Ã(»çÀÌŬ·Î½ºÆ÷¸°)ÀÇ µÎ °¡Áö ¾à¹°ÀÌ ÀÖ½À´Ï´Ù. ÀÌ µÎ °¡Áö È¿°úÀûÀÎ ¸é¿ª¾ïÁ¦Á¦´Â 20³â ÀÌ»ó ½ÅÀå ÀÌ½Ä È¯ÀÚ¿¡°Ô »ç¿ëµÇ¾î ¿ÔÁö¸¸, µ¶¼º ÇÁ·ÎÆÄÀÏÀÌ ±¤¹üÀ§ÇÏ°Ô ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ºÏ¹Ì°¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Àå±â ÀÌ½Ä¿ë ¸é¿ª¾ïÁ¦Á¦ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Àå±â ÀÌ½Ä¿ë ¸é¿ª¾ïÁ¦Á¦ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå Àå±â ÀÌ½Ä¿ë ¸é¿ª¾ïÁ¦Á¦ ½ÃÀå : ¾à¹° Á¾·ù ºñÁî´Ï½º ºÐ¼®

Á¦5Àå Àå±â ÀÌ½Ä¿ë ¸é¿ª¾ïÁ¦Á¦ ½ÃÀå : ÀÌ½Ä À¯Çü ºñÁî´Ï½º ºÐ¼®

Á¦6Àå Àå±â ÀÌ½Ä¿ë ¸é¿ª¾ïÁ¦Á¦ ½ÃÀå : ¾à¹° Á¾·ù¿¡ ÀÇÇÑ Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Organ Transplant Immunosuppressant Drugs Market Growth & Trends:

The global organ transplant immunosuppressant drugs market size is estimated to reach USD 7.24 billion by 2030, registering a CAGR of 4.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing patient population requiring organ transplantations and increasing approval of novel products are the factors driving the market growth. However, the high procedural cost of transplantations, the disproportion in the supply and demand for organs, and uncertain reimbursement scenario are the major factors restraining the market growth.

According to the Health Resources & Services Administration and the U.S. Department of Health and Human Services, more than 113,000 people were in need of transplants as of January 2019 and 36,528 transplants were performed in 2018. Hence, there is huge demand for organ transplants that will further boost the market. Kidney transplant held the largest market share in the transplant segment and is expected to retain its leading position through the forecast period. This can be attributed to increasing demand and comparatively better availability of kidneys than other organs.

Among the drug classes, the calcineurin inhibitors are expected to dominate the global organ transplant immunosuppressant drugs market through the forecast period. There are two drugs in this drug class, Prograf (tacrolimus) and Neoral/Sandimmune (cyclosporine). Although these effective immunosuppressants have been used in kidney transplant recipients for more than 20 years, they hold extensive toxicity profiles. Asia Pacific is expected to show the highest CAGR, while North America is expected to hold the largest share during the forecast period.

Organ Transplant Immunosuppressant Drugs Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Organ Transplant Immunosuppressant Drugs Market Variables, Trends, & Scope

Chapter 4. Organ Transplant Immunosuppressant Drugs Market: Drug Class Business Analysis

Chapter 5. Organ Transplant Immunosuppressant Drugs Market: Transplant Type Business Analysis

Chapter 6. Organ Transplant Immunosuppressant Drugs Market: Regional Estimates & Trend Analysis by Drug Class and Transplant Type

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â